GTX101512
CD19 antibody [C1C3]

Eine Lieferung in diese Region ist nicht möglich.
- SKU:
- GTX101512
- Zusätzliche Namen:
- CD19 molecule , B4 , CVID3
- Anwendung:
- Flow Cytometry, WB, IHC-P, IF, ICC
- Konzentration:
- 0.21 mg/ml
- Physischer Zustand:
- Liquid
- Spezies-Reaktivität:
- Human
- Aufreinigung:
- Affinity Purified
- Lagerbedingungen:
- -20[o]C Aliquot. Avoid freeze/thaw cycles. Store undiluted., 2-8[o]C Aliquot. Avoid freeze/thaw cycles. Store undiluted., -20[o]C/-70[o]C Aliquot. Avoid freeze/thaw cycles. Store undiluted.
- Hersteller:
- Genetex
- Host:
- Rabbit
- Reaktivitäten:
- Human, Mouse
- Buffer:
- PBS, 1% BSA, 20% Glycerol, 0.025% ProClin 300.
- Immunogen:
- Recombinant protein encompassing a sequence within the Intracellular domain of human CD19. The exact sequence is proprietary.
- Klon:
- C1C3
- Uniprot:
- P15391
- Synonyme:
- B-lymphocyte antigen CD19;B-lymphocyte surface antigen B4;B4;CVID3;differentiation antigen CD19;T-cell surface antigen Leu-12
- Weitere Details:
- Lymphocytes proliferate and differentiate in response to various concentrations of different antigens. The ability of the B cell to respond in a specific, yet sensitive manner to the various antigens is achieved with the use of low-affinity antigen receptors. This gene encodes a cell surface molecule which assembles with the antigen receptor of B lymphocytes in order to decrease the threshold for antigen receptor-dependent stimulation. [provided by RefSeq]
- Versandbedingungen:
- Blue Ice
![CD19 antibody [C1C3]](https://www.genetex.com/upload/website/prouct_img/normal/GTX101512/GTX101512_40422_20150609_FACS_w_23060100_523.webp)
![CD19 antibody [C1C3]](https://www.genetex.com/upload/website/prouct_img/normal/GTX101512/GTX101512_40422_20160204_WB_M_leukocyte_w_23060100_833.webp)
![CD19 antibody [C1C3]](https://www.genetex.com/upload/website/prouct_img/normal/GTX101512/GTX101512_43397_20190531_IHC-P-FL_w_23060100_506.webp)
![CD19 antibody [C1C3]](https://www.genetex.com/upload/website/prouct_img/normal/GTX101512/GTX101512_43446_20220916_ICC_IF_22102723_787.webp)